MIP Discovery is supporting the advancement of some of the biggest issues facing the diagnostic and healthcare industries, by solving problems with a significant unmet need using rationally designed synthetic affinity reagents.
We specialise in the design, development and manufacture of nanoMIPs – synthetic affinity reagents that offer unique characteristics alongside excellent performance. Serving an international market, we are focused on developing a range of research grade materials in the fields of drugs of abuse testing and cell and gene therapy processes.
Why choose MIP Discovery for your MIP development?
Recognition by design
Our ‘recognition by design’ ethos will enable our partners to create best-in-class diagnostic tools by placing rationally designed affinity reagents at the core of their platforms and technologies.
Rational design and chemical manufacturing processes means our customers always get reproducible and scalable affinity reagents. We use our experience and expertise to eliminate risk and ensure consistency.
nanoMIPs are ethically produced and animal component free. Their chemical nature allows for use in extreme environments and harsh conditions without impacting performance.